Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (281-290 of 760) with videos related to

Pageof 76
Sort By:
Mayo Clinic Proceedings|February 5, 2025
Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary InterventionBrenden S Ingraham, Marco Valgimigli, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions|February 23, 2013
High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) studyMario Leoncini, Anna Toso, Mauro Maioli, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2013
Carboxylesterase 1 as a determinant of clopidogrel metabolism and activationHao-Jie Zhu, Xinwen Wang, Brian E Gawronski, et al.
JACC. Cardiovascular Interventions|November 21, 2017
Percutaneous Interventional Repair of an Intraoperative Right Coronary Artery TearGabriel T Faz, Amit Gupta, Fabiana Rollini, et al.
International Journal of Cardiology|November 26, 2020
Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMIAnne H Tavenier, Renicus S Hermanides, Enrico Fabris, et al.
Journal of Thrombosis and Thrombolysis|March 13, 2015
Comparison of the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in stable patients with coronary artery disease treated with dual antiplatelet therapy : The ROMAN (RanOlazine vs. aMlodipine on platelet reactivity in stable patients with CAD treated with dual ANtiplatelet therapy) studyFrancesco Pelliccia, Cesare Greco, Carlo Gaudio, et al.
Journal of Thrombosis and Thrombolysis|July 16, 2013
Pharmacodynamic effects of adjunctive high dose atorvastatin on double dose clopidogrel in patients with high on-treatment platelet reactivity depending on diabetes mellitus statusMario Leoncini, Anna Toso, Mauro Maioli, et al.
The American Journal of Cardiology|March 11, 2008
Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantationRoberta Rossini, Dominick J Angiolillo, Giuseppe Musumeci, et al.
International Journal of Cardiology|May 18, 2023
European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) surveyDominick J Angiolillo, David Erlinge, José Luis Ferreiro, et al.
JACC. Cardiovascular Interventions|August 6, 2021
Antithrombotic Therapy After Transcatheter Aortic Valve ReplacementDavide Capodanno, Jean-Philippe Collet, George Dangas, et al.
Pageof 76

Showing results (281-290 of 760) with videos related to

Sort By:
Pageof 76
Mayo Clinic Proceedings|February 5, 2025
Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary InterventionBrenden S Ingraham, Marco Valgimigli, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions|February 23, 2013
High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) studyMario Leoncini, Anna Toso, Mauro Maioli, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2013
Carboxylesterase 1 as a determinant of clopidogrel metabolism and activationHao-Jie Zhu, Xinwen Wang, Brian E Gawronski, et al.
JACC. Cardiovascular Interventions|November 21, 2017
Percutaneous Interventional Repair of an Intraoperative Right Coronary Artery TearGabriel T Faz, Amit Gupta, Fabiana Rollini, et al.
International Journal of Cardiology|November 26, 2020
Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMIAnne H Tavenier, Renicus S Hermanides, Enrico Fabris, et al.
Journal of Thrombosis and Thrombolysis|March 13, 2015
Comparison of the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in stable patients with coronary artery disease treated with dual antiplatelet therapy : The ROMAN (RanOlazine vs. aMlodipine on platelet reactivity in stable patients with CAD treated with dual ANtiplatelet therapy) studyFrancesco Pelliccia, Cesare Greco, Carlo Gaudio, et al.
Journal of Thrombosis and Thrombolysis|July 16, 2013
Pharmacodynamic effects of adjunctive high dose atorvastatin on double dose clopidogrel in patients with high on-treatment platelet reactivity depending on diabetes mellitus statusMario Leoncini, Anna Toso, Mauro Maioli, et al.
The American Journal of Cardiology|March 11, 2008
Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantationRoberta Rossini, Dominick J Angiolillo, Giuseppe Musumeci, et al.
International Journal of Cardiology|May 18, 2023
European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) surveyDominick J Angiolillo, David Erlinge, José Luis Ferreiro, et al.
JACC. Cardiovascular Interventions|August 6, 2021
Antithrombotic Therapy After Transcatheter Aortic Valve ReplacementDavide Capodanno, Jean-Philippe Collet, George Dangas, et al.
Pageof 76